PKM and hepatocellular carcinoma: Based on its facilitation on tumor progression, PKM2 is predicted to be a clinical prognostic indicator for many malignant cancers such as hepatocellular carcinoma, gastric cancer, tongue cancer, gallbladder cancer and esophageal squamous cell carcinoma.